John A. Fallon's Insider Trades & SAST Disclosures
John A. Fallon's most recent trade in Collegium Pharmaceutical Inc was a trade of 7,693 Common Stock done . Disclosure was reported to the exchange on May 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John A. Fallon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 7,693 | 54,843 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,792 | 47,150 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 14,035 | 37,358 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 253.20 per share. | 21 May 2021 | 3,587 | 14,498 (0%) | 0% | 253.2 | 908,246 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 3,587 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.60 per share. | 21 May 2021 | 3,587 | 20,320 (0%) | 0% | 40.6 | 145,632 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.87 per share. | 21 May 2021 | 2,235 | 16,733 (0%) | 0% | 28.9 | 64,524 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 2,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 253.61 per share. | 21 May 2021 | 2,235 | 18,085 (0%) | 0% | 253.6 | 566,808 | Common Stock |
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 9,941 | 23,323 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.87 per share. | 04 Nov 2020 | 3,000 | 17,498 (0%) | 0% | 28.9 | 86,610 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 3,000 | 2,235 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 04 Nov 2020 | 3,000 | 14,498 (0%) | 0% | 230 | 690,000 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 02 Nov 2020 | 4,000 | 14,498 (0%) | 0% | 225 | 900,000 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.11 per share. | 02 Nov 2020 | 4,000 | 18,498 (0%) | 0% | 35.1 | 140,440 | Common Stock |
| Insulet Corporation | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,029 | 14,498 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 8,095 | 8,095 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 4,047 | 13,382 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges